← Catalyst calendarCGON biotech catalysts & pipeline
CG ONCOLOGY INC · Data as of 2026-10-25
Upcoming catalysts
cretostimogene — Full data
2026
• BOND-003 Cohort C (HR BCG-unresponsive NMIBC in Ta/T1 disease without CIS), BOND-003 Cohort P (HR BCG-unresponsive NMIBC in Ta/T1 disease without CIS), and CORE-008 Cohort A (HR BCG-naïve NMIBC with CIS +/- Ta/T1), durability data in 2026
Source filingcretostimogene — Full data
2026
BOND-003 Cohort C long-term data expected 2026
Source filingcretostimogene — Clinical data readout
2H'26
CORE-008 Cohort A updated results expected 2H'26
Source filingcretostimogene grenadenorepvec — NDA/BLA submission
Q4 2026
BLA completion for HR BCG-unresponsive NMIBC expected fourth quarter 2026
Source filingExplore the free biotech catalyst calendar
